Pfizer’s BOSULIF® (bosutinib) receives conditional marketing authorization from the European Commission
“I’m delighted the EC has approved BOSULIF..."
28 March 2013 | By Pfizer
“I’m delighted the EC has approved BOSULIF..."
List view / Grid view
“I’m delighted the EC has approved BOSULIF..."
28 March 2013 | By Pfizer
“I’m delighted the EC has approved BOSULIF..."
Conditional marketing authorization for XALKORI® in the EU granted...
24 October 2012 | By Pfizer
Conditional marketing authorization for XALKORI® in the EU granted...
The European Commission has granted marketing authorization for INLYTA® (axitinib)...
4 September 2012 | By Pfizer
The European Commission has granted marketing authorization for INLYTA® (axitinib)...
EMA accepted Pfizer’s regulatory submissions for review of two investigational…
17 August 2011 | By Pfizer
EMA accepted Pfizer’s regulatory submissions for review of two investigational compounds...